ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Rheumatology

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

20,184Medicare Part D Prescriptions Filled, Including Refills

Rank: 1 out of 295

$1.62M Total Retail Price of All Prescriptions

Rank: 1 out of 295

605 Patients Receiving at Least One Drug in Part D
84%Patients 65 Years and Older
91% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New York
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 605 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

4% of this provider’s 605 patients filled at least one prescription for a schedule three drug, compared to an average of 5%.

Risky Drugs to Seniors

1% of this provider’s 17,142 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

34% of this provider’s prescriptions were for brand-name drugs, compared to an average of 29%.

Prescription Price

$80 was the average price of a prescription from this provider, compared to $161 among peers.

Prescriptions per Patient

33 is the average number of prescriptions (including refills) per patient, compared to an average of 10.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New York
SIMVASTATIN 1,148 983 1 10
LOVAZA 655 544 2 53
OMEPRAZOLE 643 515 3 11
GABAPENTIN 540 433 4 8
LACTULOSE 502 384 5 61
LEVOTHYROXINE SODIUM 478 399 6 15
CARVEDILOL 461 384 7 59
PREDNISONE 438 353 8 1
METFORMIN HCL 402 336 9 28
NEXIUM 368 317 10 33
CRESTOR 340 309 11 38
JANUVIA 335 315 12 49
DONEPEZIL HCL 303 291 13 55
HYDROXYCHLOROQUINE SULFATE 301 219 14 3
HYDROCHLOROTHIAZIDE 288 249 15 26
SERTRALINE HCL 285 254 16 81
LISINOPRIL 264 246 17 19
AMLODIPINE BESYLATE 255 222 18 13
METOPROLOL TARTRATE 240 210 19 31
URSODIOL 233 200 20 106
SPIRONOLACTONE-HCTZ 227 184 21 107
LOSARTAN POTASSIUM 224 198 22 42
FUROSEMIDE 222 216 23 25
NAMENDA 210 192 24 77
CLOTRIMAZOLE-BETAMETHASONE 208 174 25 89
MELOXICAM 206 181 26 7
GLIMEPIRIDE 202 194 27 99
CLOPIDOGREL 200 184 28 73
ATENOLOL 197 162 29 35
JANUMET 190 186 30 118
DOXYCYCLINE HYCLATE 190 113 30 118
METOPROLOL SUCCINATE 186 174 32 32
SULFAZINE EC 179 117 10 33 92
ALENDRONATE SODIUM 178 151 34 9
ADVAIR DISKUS 176 124 35 101
SULFASALAZINE DR 172 136 36 72
ENALAPRIL MALEATE 169 153 37 66
MECLIZINE HCL 166 139 38 124
METHOTREXATE 152 126 39 2
AMITRIPTYLINE HCL 148 110 R 40 68
AMMONIUM LACTATE 148 138 40 87
ZOLPIDEM TARTRATE 147 142 42 20
ALLOPURINOL 143 131 43 12
METFORMIN HCL ER 143 118 43 95
TRAZODONE HCL 143 119 43 52
DIOVAN 142 127 46 69
WARFARIN SODIUM 140 117 47 27
SINGULAIR 134 103 48 94
LIDODERM 129 116 49 43
PLAVIX 128 116 50 84
ATORVASTATIN CALCIUM 119 107 51 23
DIOVAN HCT 118 113 52 105
COLCRYS 118 112 52 17
TRAMADOL HCL-ACETAMINOPHEN 118 105 52 34
MIRTAZAPINE 112 97 55 62
TAMSULOSIN HCL 106 106 56 70
TRAMADOL HCL 106 102 56 5
RANITIDINE HCL 104 98 58 50
MONTELUKAST SODIUM 102 82 59 120
SULFAMETHOXAZOLE-TRIMETHOPRIM 100 81 60 148
SPIRONOLACTONE 98 76 61 97
CIPROFLOXACIN HCL 95 89 62 114
ENBREL 92 82 63 6
LOSARTAN-HYDROCHLOROTHIAZIDE 89 75 64 110
ACARBOSE 89 79 64 154
VOLTAREN 83 74 66 40
PAROXETINE HCL 81 71 67 160
AMOXICILLIN 74 64 68 169
LANSOPRAZOLE 72 63 69 170
ESCITALOPRAM OXALATE 72 71 69 141
CHOLESTYRAMINE 71 55 71 171
NITROGLYCERIN PATCH 71 66 71 171
LANTUS SOLOSTAR 70 68 73 175
IBUPROFEN 68 55 74 57
VENTOLIN HFA 66 51 75 178
PRANDIN 66 66 75 178
SPIRIVA 66 66 75 137
SULFASALAZINE 61 52 78 39
METRONIDAZOLE 58 55 79 192
FAMOTIDINE 57 48 80 88
PROAIR HFA 55 26 81 200
OXYCODONE-ACETAMINOPHEN 55 47 S2 81 46
MICARDIS HCT 53 51 83 209
DILTIAZEM 24HR ER 50 38 84 144
HUMIRA 50 31 84 16
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 21, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.